- Home
- IMMP vs NRO Comparison
IMMP vs NRO Comparison
Compare IMMP & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- NRO
- Stock Information
- Founded
- IMMP 1987
- NRO 2003
- Country
- IMMP Australia
- NRO United States
- Employees
- IMMP N/A
- NRO N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- NRO Finance/Investors Services
- Sector
- IMMP Health Care
- NRO Finance
- Exchange
- IMMP Nasdaq
- NRO Nasdaq
- Market Cap
- IMMP 251.8M
- NRO 203.4M
- IPO Year
- IMMP N/A
- NRO N/A
- Fundamental
- Price
- IMMP $1.97
- NRO $3.15
- Analyst Decision
- IMMP Buy
- NRO
- Analyst Count
- IMMP 1
- NRO 0
- Target Price
- IMMP $7.00
- NRO N/A
- AVG Volume (30 Days)
- IMMP 120.6K
- NRO 239.4K
- Earning Date
- IMMP 10-10-2025
- NRO 01-01-0001
- Dividend Yield
- IMMP N/A
- NRO 11.41%
- EPS Growth
- IMMP N/A
- NRO N/A
- EPS
- IMMP N/A
- NRO N/A
- Revenue
- IMMP $3,306,742.00
- NRO N/A
- Revenue This Year
- IMMP $16.82
- NRO N/A
- Revenue Next Year
- IMMP N/A
- NRO N/A
- P/E Ratio
- IMMP N/A
- NRO N/A
- Revenue Growth
- IMMP 31.28
- NRO N/A
- 52 Week Low
- IMMP $1.32
- NRO $2.51
- 52 Week High
- IMMP $2.71
- NRO $3.45
- Technical
- Relative Strength Index (RSI)
- IMMP 63.51
- NRO 39.22
- Support Level
- IMMP $1.75
- NRO $3.19
- Resistance Level
- IMMP $2.10
- NRO $3.25
- Average True Range (ATR)
- IMMP 0.09
- NRO 0.04
- MACD
- IMMP 0.03
- NRO -0.01
- Stochastic Oscillator
- IMMP 74.79
- NRO 0.00
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").